Earnings Feed
Start Free
Edwards Lifesciences Corp·4

May 11, 9:33 PM ET

Markowitz Wayne 4

Research Summary

AI-generated summary

Updated

Edwards (EW) CVP Wayne Markowitz Receives Awards, Sells 593 Shares

What Happened

  • Wayne Markowitz, CVP, JAPAC at Edwards Lifesciences (EW), received equity awards on May 7, 2026 and disposed of shares in connection with tax withholding and an open-market sale. The filing shows grant/award acquisitions of 5,200 RSUs, a target 26,400 performance RSUs, and 5,200 option-type awards (all reported at $0.00 on the Form 4).
  • Dispositions recorded: 264 shares withheld/surrendered for taxes on 2026-05-07 at $83.20 ($21,965), 226 shares withheld on 2026-05-08 at $82.76 ($18,704), and an open-market sale of 593 shares on 2026-05-11 at $79.73 ($47,280). Combined proceeds/withholdings across those disposals ≈ $87,949.

Key Details

  • Transaction dates & prices:
    • 2026-05-07: Award — 5,200 RSUs @ $0.00 (F1); Award — 5,200 options (derivative) @ $0.00 (F2); Performance RSU Target — 26,400 shares @ $0.00 (F3).
    • 2026-05-07: 264 shares disposed for tax withholding @ $83.20 = $21,965 (code F).
    • 2026-05-08: 226 shares disposed for tax withholding @ $82.76 = $18,704 (code F).
    • 2026-05-11: Open-market sale of 593 shares @ $79.73 = $47,280 (code S).
  • Shares owned after the transactions: not specified in the provided excerpt of the filing.
  • Footnotes: RSUs vest in four equal annual installments beginning one year after grant (F1); options vest in four equal annual installments beginning one year after grant (F2); performance RSUs (target 26,400) vest May 7, 2029 based on performance (0%–200% of target) (F3).
  • Filing timeliness: Transactions dated May 7 were reported on the Form 4 filed May 11, 2026 — within the standard two-business-day reporting window.

Context

  • The two disposals coded "F" reflect shares surrendered to cover taxes related to the awards (tax withholding), while the "S" transaction is an open-market sale (593 shares). Tax-withholding disposals are routine after grant/vesting and do not necessarily indicate a change in sentiment.
  • The grants include time-based RSUs, stock-option awards, and performance-based RSUs (the latter can pay out between 0%–200% of target depending on performance).